Stock TOMDF TODOS MEDICAL LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Todos Medical Ltd.

Equities

TOMDF

IL0011392375

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 01:07:29 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Todos Medical Ltd. 0.00% -99.50%
2023 Todos Announces Notice of Allowance from Uspto for Patent Application Covering Use of Compositions in Tollovid?? and Tollovir?? Ingredients CI
2023 Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021
Capitalization 1 59.43 10.74 4.119 29.73 57.03
Enterprise Value (EV) 1 59.4 11.31 7.957 40.23 88.59
P/E ratio -22.1 x -23.2 x -0.31 x -0.65 x -0.92 x
Yield - - - - -
Capitalization / Revenue - - - 5,708,697 x 4,662,830 x
EV / Revenue - - - 7,726,750 x 7,243,615 x
EV / EBITDA -45.2 x -8.35 x -2.28 x -2.84 x -10.4 x
EV / FCF -102 x -22.9 x 21.3 x -6.67 x -4.16 x
FCF Yield -0.98% -4.36% 4.69% -15% -24%
Price to Book -44.5 x -8.91 x -0.66 x -2.56 x -2.36 x
Nbr of stocks (in thousands) 69,917 71,600 102,969 396,336 975,644
Reference price 2 0.8500 0.1500 0.0400 0.0750 0.0584
Announcement Date 5/15/18 3/28/19 6/15/20 4/21/21 3/31/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales - - - - 5.207 12.23
EBITDA 1 -0.7082 -1.314 -1.353 -3.486 -14.16 -8.523
EBIT 1 -0.7289 -1.338 -1.379 -3.515 -14.26 -9.286
Operating Margin - - - - -273.88% -75.93%
Earnings before Tax (EBT) 1 -0.6535 -2.675 -0.4575 -11.81 -29.77 -43.31
Net income 1 -0.6535 -2.675 -0.4575 -11.81 -29.77 -43.31
Net margin - - - - -571.79% -354.16%
EPS 2 -0.009940 -0.0385 -0.006456 -0.1284 -0.1149 -0.0637
Free Cash Flow 1 -0.196 -0.5819 -0.4927 0.3733 -6.035 -21.29
FCF margin - - - - -115.91% -174.1%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/1/17 5/15/18 3/28/19 6/15/20 4/21/21 3/31/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt 1 0.15 - 0.57 3.84 10.5 31.6
Net Cash position 1 - 0.03 - - - -
Leverage (Debt/EBITDA) -0.2074 x - -0.4185 x -1.101 x -0.7418 x -3.703 x
Free Cash Flow 1 -0.2 -0.58 -0.49 0.37 -6.04 -21.3
ROE (net income / shareholders' equity) 140% 307% 35.8% 317% 345% 246%
ROA (Net income/ Total Assets) -104% -119% -170% -1,515% -292% -54.9%
Assets 1 0.6283 2.241 0.2696 0.7798 10.19 78.83
Book Value Per Share 2 -0.0100 -0.0200 -0.0200 -0.0600 -0.0300 -0.0200
Cash Flow per Share 2 0.0100 0.0100 0 0 0 0
Capex 1 0.03 0 0.02 0 2.03 1.1
Capex / Sales - - - - 38.99% 8.97%
Announcement Date 5/1/17 5/15/18 3/28/19 6/15/20 4/21/21 3/31/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Diagnostics & Testing

1st Jan change Capi.
TODOS MEDICAL LTD. Stock Todos Medical Ltd.
-99.50% 3.32K
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-20.45% 10.82B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+43.17% 3.25B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-35.86% 2.11B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-17.21% 2.08B
VERACYTE, INC. Stock Veracyte, Inc.
-29.81% 1.48B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+17.56% 1.02B
SEEGENE, INC. Stock Seegene, Inc.
-4.37% 733M
CAREDX, INC Stock CareDx, Inc
-37.00% 391M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-46.94% 377M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. TOMDF Stock
  4. Financials Todos Medical Ltd.